NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease

M Hesse, AW Cheever, D Jankovic, TA Wynn - The American journal of …, 2000 - Elsevier
M Hesse, AW Cheever, D Jankovic, TA Wynn
The American journal of pathology, 2000Elsevier
Mice sensitized with Schistosomamansoni eggs and IL-12 develop liver granulomas, on
subsequent infection, which are smaller and less fibrotic than those in nonsensitized mice.
The protective response is accompanied by a shift in the type-2 cytokine profile to one
dominated by type-1 cytokines. The deviated response is associated with marked increases
in inducible nitric oxide synthase (NOS-2) activity. Here, we demonstrate, by using NOS-2-
deficient mice, that the anti-inflammatory and anti-fibrotic effects of the type-1 response are …
Mice sensitized with Schistosomamansoni eggs and IL-12 develop liver granulomas, on subsequent infection, which are smaller and less fibrotic than those in nonsensitized mice. The protective response is accompanied by a shift in the type-2 cytokine profile to one dominated by type-1 cytokines. The deviated response is associated with marked increases in inducible nitric oxide synthase (NOS-2) activity. Here, we demonstrate, by using NOS-2-deficient mice, that the anti-inflammatory and anti-fibrotic effects of the type-1 response are completely NOS-2-dependent. Strikingly, despite developing a polarized type-1 cytokine response that was similar in magnitude, the egg/IL-12-sensitized NOS-deficient mice developed granulomas 8 times larger than WT mice did. There was also no decrease in hepatic fibrosis in the sensitized mutant animals. Interferon-γ-deficient mice failed to exhibit the exacerbated inflammatory response, despite displaying a marked deficiency in nitric oxide production. However, immune deviation was unsuccessful in the latter animals, which suggested that the increase in inflammation in NOS-deficient mice resulted from a polarized but nitric oxide-deficient type-1 response. These results reveal a beneficial role for NOS-2 in the regulation of inflammation and suggest that the ultimate success of Th2-to-Th1 immune deviation strategies will rely on the efficient activation of NOS-2 expression in downstream effector cells.
Elsevier